July 2024
Minister for Medical Research supports SVI’s efforts to turn science fiction into reality
Until recently, gene editing technologies were science fiction but now, Andrew’s team is developing cutting edge gene edition technologies that hope to prevent children and young adults from dying of inherited bone marrow failure syndromes.
July 2024
Sudden Cardiac Arrest Researcher Joins SVI
SVI proudly welcomes Dr Elizabeth Paratz, who has joined SVI’s Heart, Exercise and Research Trials (HEART) Lab as a Team Leader. Dr Paratz will lead a team of SVI researchers, working closely with Professor La Gerche and scientists at VCCRI, who are also undertaking research into sudden cardiac arrest.
July 2024
Funding boost for multiple myeloma research
A four-year grant of $2.9M, announced in June from the Medical Research Future Fund’s Genomics Health Futures Grant will support a multi-centre and multidisciplinary team led by SVI’s Associate Professor Elaine Sanij to identify and validate blood biomarkers to provide early detection of multiple myeloma and to monitor disease progression and response to treatment.
June 2024
2024 Scholarship Dinner
SVI's Top-up Scholarships program is a highly successful community-led fundraising initiative which has been supporting our students for more than 30 years.
June 2024
World-first research offering hope for type 1 diabetes
In 2023, Professor Tom Kay and Helen Thomas celebrated 30 years of working together. In the same year, they also published the results of their type 1 diabetes clinical trial which offers hope for the improved treatment of the condition.
June 2024
Father-Daughter Duo Walk 80km to Fund Research for Type 1 Diabetes
“Type 1 diabetes can be unpredictable and time-consuming. Despite my experience living with this disease, watching Zoe navigate the grief, anger and sadness of this diagnosis is very difficult,” Craig said.
June 2024
Finding the key to metabolic health
As an internationally recognised expert on adenosine monophosphate-activated protein kinase (AMPK), Jon is building on the work of giants in the field like SVI’s Professor Bruce Kemp, who was the first in the world to sequence the enzyme.
June 2024
SVI Charity Golf Day 2024 – Good times as par as the eye can see
Thanks to the amazing support from our sponsors, SVI's charity golf day raised $100,000 to fund research that seeks to cure some of Australia’s most prevalent diseases, including cancer, type 1 diabetes and heart disease.
June 2024
Announcing our Rising Stars
Early career researchers are the engines that drive discovery research. They strive every day to deliver science with purpose, aiming to turn science fiction into science fact.
June 2024
Support medical research and life-changing discoveries
Every dollar counts in the battle against multiple myeloma. With your support, we can fund critical research efforts aimed at developing a more precise and less invasive way to detect it, assess its progression and evaluate treatment effectiveness.
May 2024
Making precision medicine a reality for type 1 diabetes
Professor Helen Thomas has been awarded a $600,000 grant from JDRF for research aimed at moving away from the current ‘one size fits all’ approach to the treatment of type 1 diabetes.
May 2024
Swinging for Science – Meet our Golf Day Sponsors
With one week to go until our annual Charity Golf Day, SVI would like to thank our indispensable sponsors for their support. Without you, our team of over 300 staff and students would not be able to tackle some of the most critical health challenges facing society today.
May 2024
Running under a four-minute mile could be the key to a long and healthy life
A new study released on the 70th anniversary of Sir Roger Bannister’s sub-four-minute mile record has revealed the first 200 runners to follow in his footsteps also share another remarkable trait: longevity.
April 2024
Mapping the maze – New research sheds light on Idiopathic Pulmonary Fibrosis
Dr Davis McCarthy and collaborators have published a pioneering study on the genetic factors that influence the development and progression of Idiopathic Pulmonary Fibrosis (IPF), an incurable respiratory disease diagnosed in over 1,250 Australians each year.
January 2024
Wildely optimistic – Supporting research into multiple myeloma
In late 2023, Associate Professor Elaine Sanij and SVI’s Christine Martin Fellow, Dr Jian Kang, were awarded two grants by The Barrie Dalgleish Centre for Myeloma and Related Blood Cancers. Read more about how Elaine's work is being supported by someone with the disease Kare Wilde.
April 2024
New funding to support innovative cancer research
Associate Professor Elaine Sanij has been awarded a Cancer Australia Ideas Grant for her groundbreaking work on innovative cancer therapies.
March 2024
Blood cancer breakthrough
The head of SVI's DNA Damage & Cancer Therapy Lab, Associate Professor Elaine Sanij and her collaborators have made a remarkable breakthrough on a new way to potentially treat one of the most common and aggressive forms of blood cancer.
February 2024
Congratulations to Professor André La Gerche
Congratulations to André La Gerche on his promotion to Professor.
February 2024
Congratulations to Dr Matthew Lacorcia
Matt has been awarded a JDRF Postdoctoral Fellowship for his work on developing an early diagnostic test for type 1 diabetes.
October 2023
The heart of it
Congratulations to Associate Professor Jon Oakhill who has been awarded a Heart foundation Vanguard grant to test a potential new drug treatment for a common underlying cause of cardiovascular disease.